Q&A Document on QP Declaration updated

Recommendation
10/11 September 2025
Understand the Implications of becoming a QP
The joint Q&A of CMDh and CMDv on the QP Declaration has been updated and was now published a revision 8 (CMDh/340/2015/Rev.8).
The answer (Verterinary) to question 7 was updated, with the subtraction of the final paragraph:
"In addition, it should be noted that in accordance with the requirements of VRA E.II.1 and CMDv's published Q&As on variations (specifically 2.11 and 2.12), it is also possible, as a means of "otherwise transmitted", to include any new QP declaration(s), which reflect the positive outcomes of any new site audits as part of any one of these chapter F variations and this approach is encouraged. In these cases, no separate variation application for the change in the audit date has to be submitted. However, the change has to be clearly mentioned in the scope of the application form as well as under "present/proposed". [deleted]
Other updates and additions from the previous version are highlighted in red throughout this document.
Related GMP News
20.08.2025What is the FDA Post-Warning Letter Meeting?
20.08.2025European Pharmacopoeia: New Online-only Platform
20.08.2025Events in an Audit Trail and Determination of GMP-Relevant Data in the Audit Trail
20.08.2025The Importance of Knowledge Management in GMP
13.08.2025FDA assesses economic Benefits of investing in Quality Management
13.08.2025How to Deal with Audit Trails in Preconfigured Equipment?